Yu SS - Search Results

1

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.

Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS. Bensen WG, et al. Among authors: yu ss. Mayo Clin Proc. 1999 Nov;74(11):1095-105. doi: 10.4065/74.11.1095. Mayo Clin Proc. 1999. PMID: 10560596 Clinical Trial.

2

Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.

Rao TS, Yu SS, Djuric SW, Isakson PC. Rao TS, et al. Among authors: yu ss. J Lipid Mediat Cell Signal. 1994 Sep;10(3):213-28. J Lipid Mediat Cell Signal. 1994. PMID: 7812673

3

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, AndersonGD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY, Isakson PC. Penning TD, et al. Among authors: yu ss. J Med Chem. 1997 Apr 25;40(9):1347-65. doi: 10.1021/jm960803q. J Med Chem. 1997. PMID: 9135032

4

Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib.

Zhao SZ, McMillen JI, Markenson JA, Dedhiya SD, Zhao WW, Osterhaus JT, Yu SS. Zhao SZ, et al. Among authors: yu ss. Pharmacotherapy. 1999 Nov;19(11):1269-78. doi: 10.1592/phco.19.16.1269.30879. Pharmacotherapy. 1999. PMID: 10555933 Clinical Trial.

5

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS. Simon LS, et al. Among authors: yu ss. JAMA. 1999 Nov 24;282(20):1921-8. doi: 10.1001/jama.282.20.1921. JAMA. 1999. PMID: 10580457 Clinical Trial.

6

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial.

Leese PT, Hubbard RC, Karim A, Isakson PC, Yu SS, Geis GS. Leese PT, et al. Among authors: yu ss. J Clin Pharmacol. 2000 Feb;40(2):124-32. doi: 10.1177/00912700022008766. J Clin Pharmacol. 2000. PMID: 10664917 Clinical Trial.

7

Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee.

Williams GW, Hubbard RC, Yu SS, Zhao W, Geis GS. Williams GW, et al. Among authors: yu ss. Clin Ther. 2001 Feb;23(2):213-27. doi: 10.1016/s0149-2918(01)80004-7. Clin Ther. 2001. PMID: 11293555 Clinical Trial.

8

Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib.

Zhao SZ, Fiechtner JI, Tindall EA, Dedhiya SD, Zhao WW, Osterhaus JT, Yu SS. Zhao SZ, et al. Among authors: yu ss. Arthritis Care Res. 2000 Apr;13(2):112-21. doi: 10.1002/1529-0131(200004)13:2<112::aid-anr5>3.0.co;2-l. Arthritis Care Res. 2000. PMID: 14635284 Clinical Trial.

9

Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trial.

Williams GW, Ettlinger RE, Ruderman EM, Hubbard RC, Lonien ME, Yu SS, Zhao W, Geis GS. Williams GW, et al. Among authors: yu ss. J Clin Rheumatol. 2000 Apr;6(2):65-74. doi: 10.1097/00124743-200004000-00002. J Clin Rheumatol. 2000. PMID: 19078452

10

Observation of Seven Astrophysical Tau Neutrino Candidates with IceCube.

Abbasi R, Ackermann M, Adams J, Agarwalla SK, Aguilar JA, Ahlers M, Alameddine JM, Amin NM, Andeen K, Anton G, Argüelles C, Ashida Y, Athanasiadou S, Axani SN, Bai X, Balagopal VA, Baricevic M, Barwick SW, Basu V, Bay R, Beatty JJ, Becker Tjus J, Beise J, Bellenghi C, Benning C, BenZvi S, Berley D, Bernardini E, Besson DZ, Blaufuss E, Blot S, Bontempo F, Book JY, Boscolo Meneguolo C, Böser S, Botner O, Böttcher J, Bourbeau E, Braun J, Brinson B, Brostean-Kaiser J, Burley RT, Busse RS, Butterfield D, Campana MA, Carloni K, Carnie-Bronca EG, Chattopadhyay S, Chau N, Chen C, Chen Z, Chirkin D, Choi S, Clark BA, Classen L, Coleman A, Collin GH, Connolly A, Conrad JM, Coppin P, Correa P, Cowen DF, Dave P, De Clercq C, DeLaunay JJ, Delgado D, Deng S, Deoskar K, Desai A, Desiati P, de Vries KD, de Wasseige G, DeYoung T, Diaz A, Díaz-Vélez JC, Dittmer M, Domi A, Dujmovic H, DuVernois MA, Ehrhardt T, Eller P, Ellinger E, El Mentawi S, Elsässer D, Engel R, Erpenbeck H, Evans J, Evenson PA, Fan KL, Fang K, Farrag K, Fazely AR, Feigl N, Fiedlschuster S, Fienberg AT, Finley C, Fischer L, Fox D, Franckowiak A, Fritz A, Fürst P, Gallagher J, Ganster E, Garcia A, Gerhardt L, Ghadimi A, Glaser C, … See abstract for full author list ➔ Abbasi R, et al. Phys Rev Lett. 2024 Apr 12;132(15):151001. doi: 10.1103/PhysRevLett.132.151001. Phys Rev Lett. 2024. PMID: 38682982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,216 results

Search Page

Filters